Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abbreviated, advance, agency, allegedly, Amitriptyline, assisted, calendar, Carolina, Chancery, Charlotte, choice, CIA, clarification, clarified, Clayton, cleared, commoditized, confirm, confirming, conform, Connecticut, Corrupt, deemed, detect, device, disapproval, diversified, diversion, divested, Dollar, Doxazosin, DPA, durable, education, educational, equivalent, evidence, expend, exploratory, extension, faithful, Fat, faulty, FDCA, found, fraudulent, furnishing, geographical, goal, good, harmed, Hip, hired, Hyclate, implant, implanted, importantly, impose, improperly, inappropriate, Independent, induce, ineffective, Influenced, infrequent, Interbank, interpretation, knowingly, larger, learned, LIBOR, London, lost, maker, media, Medicare, Mesylate, Methotrexate, misleading, misrepresentation, misused, monetary, negligent, neutral, older, opportunity, Oregon, Oxybutynin, payer, Pharmacy, physician, Plantar, Plea, preclude, precluded, premier, prescribe, prescribed, pretax, proceed, proven, published, qualitative, quantitative, rationalize, reconsideration, referral, representation, reputation, retroactive, side, Sodium, solid, specialist, speculation, Statute, strict, stripping, taxable, Tecum, top, tort, ultra, unapproved, uncertain, uncertainty, uncleared, unpatentable, unsafe, uterine, wide, widely, willfully, wind, winding, withheld, withhold, withholding
Removed:
accreted, acquire, acquiring, Actient, acute, Ad, adult, advisory, affirmatively, agonist, allocating, anniversary, announcement, approve, approximation, area, assertion, assume, Atlantic, attention, authorizing, banc, Barr, bearing, BEMA, BioDelivery, bioerodible, BioPharma, Branch, Buccal, bulk, buprenorphine, buyback, call, cancelled, capacity, CCH, certainty, close, clostridium, cluster, collaborate, collagenase, comment, commercializing, commercially, complying, conclusion, consolidation, constitute, consummation, convened, coupon, criteria, DAVA, death, deduction, default, defaulted, deficit, delivery, demonstration, depend, designee, Deutsche, diagnosed, difficulty, diluent, disorder, DosePro, dysfunction, dyskinesia, earned, edex, efficacy, element, embedded, en, enacted, ENDP, endpoint, ENL, Enterprise, entry, equated, erectile, ERP, essential, establish, European, excise, exercised, expansion, expressly, extend, extended, extending, facilitating, factor, fail, fall, Film, Finco, Food, forecasted, Fort, Frozen, generation, guaranteeing, hand, HCl, headquartered, hedging, histolyticum, historic, hyperactivity, hypogonadism, identification, implementation, important, incurrence, informal, informed, initially, institutional, instrumentation, insufficient, Irish, irrevocable, Jersey, JHS, jointly, Judge, Kentucky, lattice, leasehold, led, Lee, lidocaine, lipoma, liquidation, list, literature, Los, maintained, male, Mallinckrodt, manufactured, mark, marked, MCP, medicine, member, merged, metoclopramide, migraine, mild, moderate, modified, Montreal, movement, mucoadhesive, nasal, Natesto, NDA, negotiated, niche, nineteen, noted, Noven, obligate, observance, occurrence, Oklahoma, open, orderly, organized, oversubscription, owner, Parent, partial, patch, path, patient, percent, performed, perpetual, Pharmacal, PIII, PIV, placebo, Planning, preceding, preference, premarket, premium, prepaid, profit, progression, Promotora, proposal, proposing, propoxyphene, proration, prospective, proximate, proxy, Pty, punctual, purpose, put, qualifying, recalculate, receptor, reclassify, recommendation, recommended, redeem, redeemable, refinance, reflecting, registrant, registration, reimbursable, reimburse, reimbursement, reinvestment, reliant, renewal, reorganization, repayment, representative, repurchased, resale, Resource, responding, retired, retropubic, retrospective, returned, revision, RICO, Rule, secondary, semiannually, sequential, serve, shareholder, shelf, shortfall, Shoulder, significance, sitting, sixteen, Sociedad, sourcing, SRL, statistical, statistically, STENDRA, substance, successor, sumatriptan, Sumavel, supplier, surveillance, suspended, symbol, syndrome, tangible, tardive, tentative, territory, Testificandum, testimony, therapy, threshold, tier, tiered, timeframe, Toronto, TOT, transient, transmucosal, transobturator, treated, Trimel, ultimately, undertaken, undiscounted, Union, urogynecologic, urogynecological, urological, variability, vary, vested, volatility, website, whichever, writing, xiapex, Zogenix
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.5.1 Noramco 3RD Amendment to Supply Agreement
- 10.5.2 Noramco 4TH Amendment to Supply Agreement
- 10.5.3 Noramco 5TH Amendment to Supply Agreement
- 10.22 Form of Stock Option Agreement
- 10.23 Form of Stock Award Agreement
- 10.24 Form of Performance Award Agreement
- 10.28.1 Novartis Sandoz Endo Letter Agreement
- 10.35 Form of Indemnification Agreement
- 31.1 CEO Section 302 Certification
- 31.2 CFO Section 302 Certification
- 32.1 CEO Section 906 Certification
- 32.2 CFO Section 906 Certification
- Download Excel data file
- View Excel data file
ENDPQ similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Rajiv De Silva, as President and Chief Executive Officer of Endo International plc (the Company), hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2016 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/S/ RAJIV DE SILVA | |||
Name: | Rajiv De Silva | ||
Title: | President and Chief Executive Officer (Principal Executive Officer) |
Date: May 6, 2016
A signed original of this written statement required by Section 906 has been provided to, and will be retained by, Endo International plc and furnished to the Securities and Exchange Commission or its staff upon request.